Pharmas subleasing excess suburban space - Boston Business Journal:

kdrummondbs37.blogspot.com
and are among companiesw that have listed space for sublease at theidr respectiveWaltham headquarters. Both companies moved operations from the life sciencer hub of Cambridge to Waltham last Altus is listing morethan 150,000 square feet of officer and lab sublease space at the Park in Earlier this year the biopharmaceutical company (Nasdaq: ALTU) announced it woul d lay off 75 percent of its employees, leavingy 35 people at its Waltham headquarters, according to published ImmunoGen (Nasdaq: IMGN) is subleasing 14,000 squar feet of the nearly 90,009 square feet of lab spacw it leases at 830 Winted St. in Waltham.
Immunogen planned to grow into excess space at 830 Winter but has decidefd tosublease instead, sources said. This monty ImmunoGen announced it would discontinue the internaol development ofa gastric-cancerf drug. According to published reports, the company said the step will not have impact onits revenue, expensesa or cash reserves. ImmunoGen booked $23.7 million in revenuw and a net lossof $21.1 million during the nine months endesd March 31.